Description
+ Include: 51 Videos (.mp4) + 51 Audios (.mp3) + 51 Subtitles (.vtt) + 51 PDFs, size: 11.1 GB
+ Target Audience: interventional cardiologists, cardiac surgeons
+ Sample video: contact me for sample video
+ Information:
1. Overview
The University of Miami Miami Valves 2025 is a premier structural heart disease conference focusing on the latest innovations in transcatheter valve therapies. The course provides a deep dive into TAVR, TMVR, and tricuspid interventions, alongside cutting-edge research on AI integration and novel device clinical trials.
Course Date: 2025
2. Learning Objectives
-
Evaluate recent clinical trial data for TAVR, including the PROPEL and EASY II trials.
-
Discuss the management of complex aortic valve cases, such as bicuspid anatomy and chronic aortic regurgitation.
-
Analyze emerging technologies for mitral valve repair and replacement, focusing on TEER durability and neo-LVOT simulation.
-
Review FDA-approved and investigational therapies for tricuspid regurgitation, including replacement and edge-to-edge repair.
-
Implement novel techniques for structural interventions, including PFO closure in older adults and management of paravalvular leaks.
3. Target Audience
Best for interventional cardiologists and cardiac surgeons who want updates on structural heart disease and transcatheter valve therapies.
4. Topics
-
What Did We Learn from TAVR UNLOAD
-
Selected Case of CE Approved TAVR Valve – Acurate Neo2
-
Hybrid TAVR
-
Septal Occulders- Not Just for the Intra-Atrial Septum
-
Novel Vascular Closure Device (xDot) – First in Human Experience
-
AI for Cardiovascular Staff Support
-
Novel RV Restoration System
-
Novel TMVR Devices
-
Latest Clinical Update – Silara MiBridge. Direct Annuloplasty System
-
Novel Transcatheter Mitral Annuloplasty Repair. Technology and Pre-Clinical Experience
-
EASY II Trial – Pioneering Temporary A-V Sequential Pacing for Enhanced Cardiac Care
-
Novel Device for Pulmonic Valve – Alterra
-
Tricuspid Valve Replacement in a Patient with a Torn Leaflet
-
Understanding the Tricuspid Regurgitation (Pathologist Perspective)
-
Multi Modality Imaging of Tricuspid Valve
-
Surgical Treatment of Tricuspid Valve
-
FDA Approved Edge to Edge Repair of Tricuspid (What We Know)
-
FDA Approved Tricuspid Valve Replacement – What We Know
-
TTVR with the Evoque Valve via the Transjugular Approach
-
Expanding Indications for PFO Closure Patients ≥ 60-Years Old
-
A Case of Severe Bioprosthetic Valve Dysfunction
-
Neo-LVOT Simulations for TMVR
-
Preventing LVOT Obstruction During TMVR – Septal Reduction and LAMPOON – What We Know
-
TMVR and the Tendyne Roll-In and MAC Experience
-
APOLLO Trial MAC Cohort
-
Investigational Transeptal TMVR – SAPIEN M3
-
ViMAC with SUPERMAN
-
Imaging to Plan Mitral Valve Procedures
-
Durability of Edge-to-Edge Repair
-
TEER in Moderate MR
-
Recurrent Heart Failure after M-TEER – More than the Mitral Valve
-
Clinical Trials for Mitral Regurgitation Beyond TEER – Where to Next
-
Progress in Mitral Valve Replacement
-
LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve Replacement
-
Pathological Insights to the Native Aortic Valve Regurgitation
-
Dedicated TAVR Devices for Chronic Aortic Regurgitation
-
Single Center Results for a Balloon Expandable Valve in Native Valve AI
-
Where Are We with TAVR for Bicuspid
-
AI Simulation Assisted TAVR
-
A Case of Bicuspid TAVR with AI Planning
-
TAVR 2025 – The Begins….
-
TAVR US Origin
-
Clinical Trial Propel TAVR Forward – Building the Evidence Base for Low Surgical Risk Patients
-
Late PVL After BE THV
-
Transcatheter Management of Failed Ross Procedure
-
Short Term ACS Post TAVR
-
On the Shoulders of Our Mentors… How to Maximize Your Career Development Pathway
-
Left Atrium to Coronary Sinus Shunting – Edwards’ APTURE Shunt and ALT-FLOW II Trial
-
Transcatheter Treatment of a Sinus Venous ASD with Partial Anomalous Pulmonary Venous Return
-
Percutaneous Tricuspid Valve Intervention(s)
-
Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction
Reviews
There are no reviews yet.